[DSCI] Derma Sciences, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 104.34 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 5.4 Change: 0.2 (3.85%)
Ext. hours: Change: 0 (0%)

chart DSCI

Refresh chart

Description: Derma Sciences, Inc. operates as a tissue regeneration company in the wound care market. It operates in three segments: Advanced Wound Care, Traditional Wound Care, and Pharmaceutical Wound Care. The company offers Medihoney dressings for managing non-chronic and hard-to-heal wounds, such as chronic ulcers, burns, and post-operative wounds; TCC-EZ total contact cast system for patients with diabetic foot ulcers; AMNIOEXCEL for tissue repair and regeneration; and AMNIOMATRIX, which is used as a wound covering in the treatment of localized tissue defects. It also provides Xtrasorb dressings that convert fluid within the dressings to a gel and lock the exudates into the dressings; Bioguard dressings for prophylactic use in the prevention of hospital or community acquired infections through wound sites; ALGICELL AG antimicrobial dressings; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and DERMAGRAN products. In addition, the comp

Fundamental Ratios
Shares Outstanding25.89 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -6.77% Sales Growth - Q/Q-14.75% P/E
P/E To EPS Growth P/S1.25 P/BV0.88 Price/Cash Per Share1.57
Price/Free Cash Flow-3.76 ROA-30.54% ROE-33.94% ROI
Current Ratio8.53 Quick Ratio7.08 Long Term Debt/Equity Debt Ratio0.09
Gross Margin36.82% Operating Margin-47.95% Net Profit Margin-48.06% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.82 M Cash From Investing Activities5.56 M Cash From Operating Activities-10.73 M Gross Profit7.54 M
Net Profit-10.61 M Operating Profit-10.23 M Total Assets131.35 M Total Current Assets93.65 M
Total Current Liabilities10.98 M Total Debt Total Liabilities13.17 M Total Revenue19.5 M
Technical Data
High 52 week7.03 Low 52 week2.98 Last close7 Last change0%
RSI50 Average true range0.55 Beta0.21 Volume28.07 K
Simple moving average 20 days0.11% Simple moving average 50 days9.86% Simple moving average 200 days41.21%
Performance Data
Performance Week0% Performance Month0.36% Performance Quart50.54% Performance Half48.31%
Performance Year112.12% Performance Year-to-date34.62% Volatility daily0.3% Volatility weekly0.68%
Volatility monthly1.38% Volatility yearly4.79% Relative Volume285.46% Average Volume428.81 K
New High New Low

News

2017-04-03 13:00:44 | Why One Analyst Sees Almost 40% Upside in Integra LifeSciences

2017-03-07 06:05:18 | DERMA SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits

2017-02-24 08:31:45 | DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or F

2017-02-23 08:30:00 | Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.

2017-02-15 09:15:00 | Integra Scoops Up JNJ's Codman Neurosurgery for $1.05B

2017-01-27 11:22:00 | INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders

2017-01-25 17:01:35 | DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers

2017-01-25 08:30:00 | Integra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc.

2017-01-23 15:21:48 | We’re in the year of the biotech buyout, and here are five prime targets

2017-01-18 09:36:31 | Derma Sciences downgraded by ROTH Capital

2017-01-17 17:26:00 | Harwood Feffer LLP Announces Investigation of Derma Sciences Inc.

2017-01-17 16:38:10 | DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen

2017-01-17 11:13:00 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders -- DSCI

2017-01-13 17:06:00 | DERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Derma Sciences, Inc. DSCI Over the Proposed Sale of the Company to Integra LifeSciences Holdings Corporation

2017-01-12 12:50:00 | INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders

2017-01-12 11:15:00 | Integra LifeSciences Buys Derma Sciences for $204M

2017-01-12 11:11:00 | DERMA SCIENCES, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Integra LifeSciences Holdings Corporation May be Unfair to Shareholders

2017-01-12 10:10:03 | Company News for January 12, 2017

2017-01-12 08:15:00 | Blog Coverage Integra Set to Acquire Derma Sciences; Announced Outlook 2017

2017-01-11 16:15:00 | Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner

2017-01-11 15:22:17 | Wednesday’s Top Biopharma Movers

2017-01-11 13:02:00 | Derma Sciences Soars Almost 40% on Buyout by Integra

2017-01-11 12:44:19 | ETFs with exposure to Derma Sciences, Inc. : January 11, 2017

2017-01-11 11:05:00 | DERMA SCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

2017-01-11 10:02:00 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders - DSCI

2017-01-11 09:33:00 | DERMA DSCI ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Derma Sciences, Inc.; Is $7 a Fair Price?

2017-01-11 07:42:12 | Integra LifeSciences at 52-Week High on Deals, View Update

2017-01-11 03:08:00 | 3:08 am Derma Sciences to be acquired by Integra LifeSciences for $7.00 per share

2017-01-10 20:00:00 | Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook

2017-01-09 06:00:00 | Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan

2016-12-16 13:35:18 | ETFs with exposure to Derma Sciences, Inc. : December 16, 2016

2016-12-09 14:36:04 | Derma Sciences Inc DSCI: Smart Money Continues to Abandon the Stock

2016-11-30 12:15:53 | ETFs with exposure to Derma Sciences, Inc. : November 30, 2016

2016-11-28 10:48:18 | Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016

2016-11-14 10:00:03 | Edited Transcript of DSCI earnings conference call or presentation 10-Nov-16 4:00pm GMT

2016-11-10 16:00:00 | Derma Sciences to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

2016-11-10 11:00:00 | Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today

2016-11-10 07:45:30 | Derma Sciences reports 3Q loss

2016-11-10 07:41:09 | Derma Sciences Reports 2016 Third Quarter Financial Results

2016-11-10 07:30:00 | Derma Sciences Reports 2016 Third Quarter Financial Results

2016-11-10 07:07:07 | Q3 2016 Derma Sciences Inc Earnings Release - Before Market Open

2016-11-09 17:24:45 | DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report

2016-11-02 16:10:40 | Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th

2016-11-02 16:00:00 | Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th

2016-10-21 17:23:18 | DERMA SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits

2016-10-05 10:16:12 | ETF’s with exposure to Derma Sciences, Inc. : October 5, 2016

2016-09-26 09:04:01 | Henry Schein HSIC Grows Through Acquisitions, Runs Risks

2016-09-23 08:43:12 | Medtronic MDT: Valiant Captivia Data Positive at Three Years

2016-09-23 08:38:12 | LabCorp: Strong Fundamentals, Sequenom Buyout Raise Hope

2016-09-21 14:02:00 | Derma Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference